Publication

TGF-beta regulates the stem-like state of PD-1(+) TCF-1(+) virus-specific CD8 T cells during chronic infection

Downloadable Content

Persistent URL
Last modified
  • 06/25/2025
Type of Material
Authors
    Yinghong Hu, Emory UniversityWilliam Hudson, Emory UniversityHaydn Kissick, Emory UniversityChrsitopher B Medina, Emory UniversityAntonio P Baptista, Ghent UniversityChaoyu Ma, University of Texas Health Science Center at San AntonioWei Liao, University of Texas Health Science Center at San AntonioRonald N Germain, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaShannon J Turley, Genentech IncRafi Ahmed, Emory University
Language
  • English
Date
  • 2022-08-18
Publisher
  • ROCKEFELLER UNIV PRESS
Publication Version
Copyright Statement
  • © 2022 Hu et al.
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 219
Issue
  • 10
Supplemental Material (URL)
Abstract
  • Recent studies have defined a novel population of PD-1+ TCF-1+ stem-like CD8 T cells in chronic infections and cancer. These quiescent cells reside in lymphoid tissues, are critical for maintaining the CD8 T cell response under conditions of persistent antigen, and provide the proliferative burst after PD-1 blockade. Here we examined the role of TGF-β in regulating the differentiation of virus-specific CD8 T cells during chronic LCMV infection of mice. We found that TGF-β signaling was not essential for the generation of the stem-like CD8 T cells but was critical for maintaining the stem-like state and quiescence of these cells. TGF-β regulated the unique transcriptional program of the stem-like subset, including upregulation of inhibitory receptors specifically expressed on these cells. TGF-β also promoted the terminal differentiation of exhausted CD8 T cells by suppressing the effector-associated program. Together, the absence of TGF-β signaling resulted in significantly increased accumulation of effector-like CD8 T cells. These findings have implications for immunotherapies in general and especially for T cell therapy against chronic infections and cancer.
Author Notes
Keywords
Research Categories
  • Health Sciences, Oncology

Tools

Relations

In Collection:

Items